Can blood work detect cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Can Blood Work Detect Cancer?
Introduction to Blood-Based Cancer Detection
Blood tests have emerged as a promising tool for the early detection of cancer. These tests aim to identify cancer-specific biomarkers, such as circulating tumor DNA (ctDNA), protein biomarkers, and other molecular markers, which can indicate the presence of cancer even before symptoms appear. This article explores the current state of research on blood-based cancer detection, highlighting key findings and advancements.
Multi-Analyte Blood Tests for Cancer Detection
CancerSEEK: A Comprehensive Blood Test
One of the most notable advancements in blood-based cancer detection is the development of CancerSEEK. This test combines the analysis of eight circulating protein biomarkers and tumor-specific mutations in ctDNA to detect eight common types of cancer, including ovarian, liver, stomach, pancreatic, esophageal, colorectal, lung, and breast cancers. In a study involving 1,005 patients with non-metastatic cancers, CancerSEEK demonstrated a sensitivity range of 69% to 98% and a specificity greater than 99%. This high specificity means that the test has a low rate of false positives, making it a reliable tool for early cancer detection.
Feasibility of Blood Testing Combined with PET-CT
Another study explored the feasibility of integrating a multicancer blood test with positron emission tomography-computed tomography (PET-CT) imaging. This approach was tested on 10,006 women with no prior history of cancer. The blood test detected 26 cancers, and PET-CT imaging confirmed and localized these cancers, leading to surgical removal in nine cases. The study concluded that combining blood tests with PET-CT is a safe and effective method for early cancer detection and localization.
Specific Blood Markers for Colorectal Cancer
Full Blood Count (FBC) and Colorectal Cancer
Research has shown that certain components of a full blood count (FBC) test, such as red blood cells, hemoglobin, mean corpuscular volume, red blood cell distribution width, white blood cell count, and platelets, are associated with colorectal cancer diagnosis. Several FBC-based prediction models have been developed, with performance metrics ranging from 0.72 to 0.91 in terms of the c-statistic, indicating their potential utility in early detection.
Systematic Review of Blood Markers
A systematic review identified 70 different blood markers for early detection of colorectal cancer. These markers include proteins, DNA, and RNA, with varying performance characteristics. Some novel assays, such as those based on mass spectrometry, have shown promising results but require further validation in larger, prospective studies.
Early Detection Using Circulating Tumor DNA
PanSeer: Non-Invasive Early Detection
The PanSeer test, which detects ctDNA methylation, has shown the ability to identify five common types of cancer (stomach, esophageal, colorectal, lung, and liver) up to four years before conventional diagnosis. In a study involving 605 asymptomatic individuals, PanSeer detected cancer in 95% of those who were later diagnosed, with a specificity of 96%. This demonstrates the potential of ctDNA-based tests for very early cancer detection.
Tumor-Origin Detection Accuracy
A meta-analysis of blood-based multi-cancer early detection (MCED) tests found that these tests could accurately determine the tissue of origin in 79% of cases. The accuracy varied across cancer types, with colorectal cancers showing the highest accuracy and liver & bile duct cancers the lowest. This information is crucial for guiding appropriate treatment and improving patient outcomes.
Conclusion
Blood-based tests for cancer detection are rapidly advancing, offering a non-invasive and potentially early method for identifying various types of cancer. Tests like CancerSEEK and PanSeer have shown high sensitivity and specificity, making them promising tools for early diagnosis. However, further research and validation are needed to fully integrate these tests into routine clinical practice and to improve their accuracy across different cancer types. Early detection through blood tests could significantly enhance treatment outcomes and reduce cancer mortality.
Sources and full results
Most relevant research papers on this topic